+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Vascular Grafts - Global Strategic Business Report

  • PDF Icon

    Report

  • 481 Pages
  • February 2025
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 4806364
The global market for Vascular Grafts was valued at US$3.9 Billion in 2024 and is projected to reach US$5.9 Billion by 2030, growing at a CAGR of 7.2% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Global Vascular Grafts Market - Key Trends & Drivers Summarized

What Are Vascular Grafts, and Why Are They Critical in Modern Medicine?

Vascular grafts are medical devices used to replace, repair, or bypass sections of blood vessels in the body, often necessitated by diseases such as atherosclerosis, aneurysms, or blockages. These grafts are crucial in cardiovascular surgeries, including coronary artery bypass grafting, which helps improve blood flow to the heart. The materials used for these grafts are specifically chosen based on their compatibility with the human body and their mechanical properties, such as flexibility and durability. Vascular grafts can be made from synthetic materials like polyester and polytetrafluoroethylene (PTFE), or from biological materials, including modified human or animal tissue.

How Have Innovations Enhanced Vascular Graft Technology?

Recent innovations in vascular graft technology have significantly improved the outcomes of vascular surgeries. The development of tissue-engineering grafts, which promote cell growth and regeneration, is one example of how this field is advancing. These grafts are designed to be biocompatible and to encourage endothelialization, where new endothelial cells grow on the inner surface of the graft, thereby reducing the risk of thrombosis and ensuring the long-term patency of the graft. Additionally, advancements in imaging and diagnostic technologies have improved the precision of graft placement, minimizing risks and potential complications during surgeries. Innovations like drug-eluting grafts that help prevent infection and restenosis further enhance the efficacy and safety of vascular interventions.

What Role Do Vascular Grafts Play in Treating Vascular Diseases?

Vascular grafts play an indispensable role in the treatment of a range of vascular diseases that can lead to severe complications and even death if left untreated. In patients with coronary artery disease, vascular grafts are used to bypass clogged arteries, helping to restore normal blood flow to the heart. For individuals suffering from peripheral arterial disease, these grafts can bypass diseased arteries in the legs, alleviating symptoms like pain and cramps and preventing limb amputation. In cases of aneurysms, particularly abdominal aortic aneurysms, grafts reinforce weak arterial walls to prevent rupture. The versatility and adaptability of vascular grafts make them essential tools in vascular surgery, providing life-saving treatments for high-risk patients.

Growth in the Vascular Grafts Market Is Driven by Several Factors

The growth in the vascular grafts market is driven by several factors, including the increasing prevalence of cardiovascular diseases globally due to aging populations and rising risk factors such as diabetes, obesity, and hypertension. Technological advancements that improve graft functionality and patient compatibility also contribute to the expansion of this market. There is a growing preference for minimally invasive surgeries, which utilize smaller, more advanced grafts that reduce recovery time and improve patient outcomes. Additionally, the rise in healthcare expenditure and the availability of more sophisticated healthcare facilities in emerging economies are expanding access to vascular graft procedures. Enhanced public awareness about the benefits of early diagnosis and treatment of cardiovascular conditions further stimulates market growth, underscoring the critical nature of vascular grafts in contemporary medical practices.

Scope of the Study

The report analyzes the Vascular Grafts market, presented in terms of market value (US$ Thousand). The analysis covers the key segments and geographic regions outlined below.

Segments:

Indication (Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair, Hemodialysis Access); Raw Material (Polyester, ePTFE, Polyurethane, Biosynthetic); End-Use (Hospitals, Ambulatory Surgical Centers).

Geographic Regions/Countries:

World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Spain; Russia; Rest of Europe; Asia-Pacific; Australia; India; South Korea; Rest of Asia-Pacific; Latin America; Argentina; Brazil; Mexico; Rest of Latin America; Middle East; Iran; Israel; Saudi Arabia; UAE; Rest of Middle East; Africa.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Endovascular Aneurysm Repair (EVAR) Indication segment, which is expected to reach US$2.6 Billion by 2030 with a CAGR of a 6.9%. The Peripheral Vascular Repair Indication segment is also set to grow at 8.7% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, valued at $1.5 Billion in 2024, and China, forecasted to grow at an impressive 8.9% CAGR to reach $687.6 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of major players such as Cardinal Health, Inc., Baxter International, Inc., Terumo Corporation, Cook Medical, LLC, Teleflex, Inc. and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Vascular Grafts Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Vascular Grafts Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Vascular Grafts Market expected to evolve by 2030?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2030?
  • Who are the leading players in the market, and what are their prospects?

Some of the 44 major companies featured in this Vascular Grafts market report include:

  • Cardinal Health, Inc.
  • Baxter International, Inc.
  • Terumo Corporation
  • Cook Medical, LLC
  • Teleflex, Inc.
  • LeMaitre Vascular, Inc.
  • MicroPort Scientific Corporation
  • iVascular S.L.U
  • Jotec GmbH
  • ParaGen Technologies
  • sunnatech scientific corporation
  • Vacis
  • Cardiovascular Systems, Inc.
  • Healionics
  • InnAVasc Medical

Table of Contents

I. METHODOLOGYMII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Vascular Grafts - Global Key Competitors Percentage Market Share in 2024 (E)
  • A Prelude to Vascular Grafting
  • Global Market Prospects and Overview
  • Vascular Grafts Market Set for a Rapid Growth
  • Endovascular Stent-Grafts Account for Larger Share
  • Competition
  • Recent Market Activity
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Increasing Incidence of Cardio Vascular Disease Bodes Well for the Global Vascular Graft Market
  • Fatalities by Heart Conditions: Estimated Percentage Breakdown for Cardiovascular Disease, Ischemic Heart Disease, Stroke, and Others
  • Global Annual Medical Cost of CVD in US$ Billion (2010-2030)
  • Rising Preference for Minimally Invasive Procedures Boosts Market Prospects
  • Rising Prevalence of Kidney Diseases Drives the Global Hemodialysis Vascular Graft Market
  • Hemodialysis Remains the Major Modality for Dialysis Treatment - A Key Opportunity
  • Global Dialysis Patient Population Distribution by Modality for Select Countries (2020): Percentage Breakdown of Hemodialysis (HD) and Peritoneal Dialysis (PD) Patients
  • Global Population of ESRD Patients Undergoing Therapy by Type of Treatment (2020): Percentage Breakdown of Patients Receiving Hemodialysis, Kidney Transplants, and Peritoneal Dialysis
  • Home Hemodialysis: A Niche Albeit High Potential Market
  • World Dialysis Clinics Market by Region (2019): Percentage Breakdown of Patients Treated by Type of Operator
  • Global Dialysis Market by Region: Percentage Breakdown of Patients Receiving Dialysis Treatment in In-Centre and Home Settings for 2019
  • Aging Population Drives Demand for Vascular Grafts
  • Increasing Healthcare Expenditure to Foster Growth
  • World Healthcare Expenditure (In US$ Trillion) for the Years 2016 & 2018
  • Rising Middle Class Population Aids Growth
  • Global Middle Class Population (in Millions) and as a Percentage of Total Population: 2005, 2015, 2025 & 2035
  • Global Middle Class Spending (in US$ Trillion) by Geographic Region
  • Risk of CAD in Obesity Offers Prospects for Coronary Stenting
  • Obesity Prevalence Rate (%) in Select Countries for the Years 2019 and 2030P
  • Cell-Free Tissue Engineered Vascular Grafts Aid in Vascular Remodeling
  • New Approach for Optimizing TEVGs
  • 3D Printed Vascular Scaffolds Hold Potential to be the New-Age TEVGs
  • A Review of Select Vascular Developments
  • Some of the important vascular innovations expected in the near-term include:
  • Offerings of Moving Analytics and Vasctrac
4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair (EVAR) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 2: World Historic Review for Endovascular Aneurysm Repair (EVAR) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 3: World 15-Year Perspective for Endovascular Aneurysm Repair (EVAR) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 4: World Recent Past, Current & Future Analysis for Peripheral Vascular Repair by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 5: World Historic Review for Peripheral Vascular Repair by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 6: World 15-Year Perspective for Peripheral Vascular Repair by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 7: World Recent Past, Current & Future Analysis for Hemodialysis Access by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 8: World Historic Review for Hemodialysis Access by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 9: World 15-Year Perspective for Hemodialysis Access by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 10: World Recent Past, Current & Future Analysis for Polyester by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 11: World Historic Review for Polyester by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 12: World 15-Year Perspective for Polyester by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 13: World Recent Past, Current & Future Analysis for ePTFE by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 14: World Historic Review for ePTFE by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 15: World 15-Year Perspective for ePTFE by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 16: World Recent Past, Current & Future Analysis for Polyurethane by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 17: World Historic Review for Polyurethane by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 18: World 15-Year Perspective for Polyurethane by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 19: World Recent Past, Current & Future Analysis for Biosynthetic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 20: World Historic Review for Biosynthetic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 21: World 15-Year Perspective for Biosynthetic by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 22: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 23: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 24: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 25: World Recent Past, Current & Future Analysis for Ambulatory Surgical Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 26: World Historic Review for Ambulatory Surgical Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 27: World 15-Year Perspective for Ambulatory Surgical Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 28: World Vascular Grafts Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Vascular Grafts by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Vascular Grafts by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Vascular Grafts by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
III. MARKET ANALYSIS
UNITED STATES
  • Vascular Grafts Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
CANADA
JAPAN
  • Vascular Grafts Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
CHINA
  • Vascular Grafts Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
EUROPE
  • Vascular Grafts Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
FRANCE
  • Vascular Grafts Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
GERMANY
  • Vascular Grafts Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
ITALY
UNITED KINGDOM
  • Vascular Grafts Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
SPAINRUSSIAREST OF EUROPE
ASIA-PACIFIC
  • Vascular Grafts Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
AUSTRALIA
  • Vascular Grafts Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
INDIA
  • Vascular Grafts Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
SOUTH KOREAREST OF ASIA-PACIFIC
LATIN AMERICA
  • Vascular Grafts Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
ARGENTINABRAZILMEXICOREST OF LATIN AMERICA
MIDDLE EAST
  • Vascular Grafts Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
IRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EAST
AFRICA
  • Vascular Grafts Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Cardinal Health, Inc.
  • Baxter International, Inc.
  • Terumo Corporation
  • Cook Medical, LLC
  • Teleflex, Inc.
  • LeMaitre Vascular, Inc.
  • MicroPort Scientific Corporation
  • iVascular S.L.U
  • Jotec GmbH
  • ParaGen Technologies
  • sunnatech scientific corporation
  • Vacis
  • Cardiovascular Systems, Inc.
  • Healionics
  • InnAVasc Medical

Table Information